Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Abdou-samad KONE"'
Autor:
Bouchra Ghazi, Zakia Harmak, Mounir Rghioui, Abdou-Samad Kone, Adil El Ghanmi, Abdallah Badou
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Over the last decades, extracellular vesicles (EVs) have become increasingly popular for their roles in various pathologies, including cancer and neurological and immunological disorders. EVs have been considered for a long time as a means for normal
Externí odkaz:
https://doaj.org/article/a563d78fe59d484eab68e961e2465870
Autor:
Abdou-samad Kone, Amina Ghouzlani, Ahmed Qandouci, Nour el Imane Issam Salah, Yann Bakoukou, Abdelhakim Lakhdar, Mehdi Karkouri, Abdallah Badou
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionGliomas represent the most prevalent and aggressive tumors within the central nervous system. Despite the current standard treatments, the median survival time for glioblastoma patients remains dismal, hovering around 14 months. While att
Externí odkaz:
https://doaj.org/article/b3ba4b6f94664490ac05a6c8b6dff319
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 21, p 13424 (2022)
Butyrophilin-3A (BTN3A) subfamily members are a group of immunoglobulins present on the surface of different cell types, including innate and cancer cells. Due to their high similarity with the B7 family members, different studies have been conducted
Externí odkaz:
https://doaj.org/article/f88903c1fb004b61bd446bd996367376
Autor:
Ahmed QANDOUCI, Oumayma Naji, Amina Ghouzlani, Abdou-samad KONE, Abdelhakim Lakhdar, Abdallah Badou
Background: Diffuse glioma is a malignant human brain cancer that is hard to overcome. This represents a high risk of mortality. The current challenge is limited to the control of tumor progression and survival improvement. Immunotherapy consists of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3cd6da244d73d6ae30a5026e8ad8b3
Background: Diffuse glioma is a malignant human brain cancer that is hard to overcome. This represents a high risk of mortality. The current challenge is limited to the control of tumor progression and survival improvement.Immunotherapy consists of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91c76c1ee7ff9dca3051e298dd5eacf3
https://doi.org/10.21203/rs.3.rs-1530119/v1
https://doi.org/10.21203/rs.3.rs-1530119/v1
Publikováno v:
The Application of Clinical Genetics. 12:51-54
Background Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is one of the most common craniofacial malformations observed. Several studies suggest that the decrease in folate has been associated with a higher risk of NSCL/P. The present s